Clinical Trial Update: Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) [Phase 3]

View source ↗

Summary

Phase 3 STRATIFY II trial comparing percutaneous embolectomy, low-dose thrombolysis, and heparin for intermediate-high risk pulmonary embolism; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: Jesper Kjaergaard | Conditions: Pulmonary Embolism | Phase 3 | Status: NOT_YET_RECRUITING